Reducing N6AMT1-Mediated 6mA DNA Modification Promotes Breast Tumor Progression via Transcriptional Repressing Cell Cycle Inhibitors

Scientists found that decreases in N6AMT1 correlated with the extent of DNA N6-methyladenosine (6mA) in clinical breast cancer (BC) tissues and predicted a worse survival of BC patients.